Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.
about
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effectiveness and safety of om ...... c hepatitis C virus infection.
@en
type
label
Effectiveness and safety of om ...... c hepatitis C virus infection.
@en
prefLabel
Effectiveness and safety of om ...... c hepatitis C virus infection.
@en
P2093
P2860
P50
P356
P1476
Effectiveness and safety of om ...... c hepatitis C virus infection.
@en
P2093
C Fernández-Rodríguez
F García-Paredes
F Jorquera
I Fernández
J C Porres
J García-Samaniego
J I Herrero
P2860
P304
P356
10.1111/JVH.12637
P577
2016-12-15T00:00:00Z